Showing results (11-20 of 13) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
JAMA Network Open|November 2, 2023
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled TrialThierry André, Dominique Berton, Giuseppe Curigliano, et al.Therapeutic Advances in Medical Oncology|September 30, 2024
Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)Annika Auranen, Matthew A Powell, Vladyslav Sukhin, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2025
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxelDana M Chase, Jørn Herrstedt, Eirwen M Miller, et al.Pageof 2